The human cathelicidin LL-37 inhibits influenza A viruses through a mechanism distinct from that of surfactant protein D or defensins.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- The human cathelicidin LL-37 inhibits influenza A viruses through a mechanism distinct from that of surfactant protein D or defensins.
- Published In:
- The Journal of general virology, 94(Pt 1), 40-49 (2013)
- Authors:
- Tripathi, Shweta, Tecle, Tesfaldet, Verma, Anamika, Crouch, Erika, White, Mitchell, Hartshorn, Kevan L
- Database ID:
- RPEP-02295
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-02295APA
Tripathi, Shweta; Tecle, Tesfaldet; Verma, Anamika; Crouch, Erika; White, Mitchell; Hartshorn, Kevan L. (2013). The human cathelicidin LL-37 inhibits influenza A viruses through a mechanism distinct from that of surfactant protein D or defensins.. The Journal of general virology, 94(Pt 1), 40-49. https://doi.org/10.1099/vir.0.045013-0
MLA
Tripathi, Shweta, et al. "The human cathelicidin LL-37 inhibits influenza A viruses through a mechanism distinct from that of surfactant protein D or defensins.." The Journal of general virology, 2013. https://doi.org/10.1099/vir.0.045013-0
RethinkPeptides
RethinkPeptides Research Database. "The human cathelicidin LL-37 inhibits influenza A viruses th..." RPEP-02295. Retrieved from https://rethinkpeptides.com/research/tripathi-2013-the-human-cathelicidin-ll37
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.